Month: <span>November 2023</span>

Home / 2023 / November
Lemon water has its health benefits, but should you drink it daily? Experts weigh in
Post

Lemon water has its health benefits, but should you drink it daily? Experts weigh in

Perri Blumberg Sun, November 5, 2023 Lemon water seems to be quite the craze on social media lately — but is the citrus-infused concoction really a boon for your health? “Drinking lemon water is currently being encouraged by several social media influencers,” April Wiles, a North Carolina-based registered dietitian and owner of thegenxdietitian.com, told Fox...

Post

Postmenopausal Stress Linked to Mood, Cognitive Symptoms

Tara Haelle October 25, 2023 Acute stress in pri- and postmenopausal women is associated with more depressive symptoms, while chronic stress showed greater association with memory and concentration problems, according to research presented at the annual meeting of the Menopause Society (formerly the North American Menopause Society). “This work suggests that markers of hypothalami-pituitary-axis activation that capture...

Post

Ketamine No Better for Depression Than Placebo?

Eve Bender October 30, 2023 TOPLINE: Ketamine was no more effective than placebo in reducing depressive symptoms in surgical patients with major depressive disorder (MDD), results of a new study, which contradict prior research, suggest. Although symptoms improved in both study groups, investigators say participants’ expectations of an improvement from ketamine may be driving that result. METHODOLOGY: TAKEAWAY:...

Post

What can cause pain on the left side of the body?

Some common causes of pain on the left side of the body include infection and injury to internal organs, muscles, or nerves. In some cases, this pain resolves on its own. However, other cases may require immediate medical intervention. It is best to contact a doctor for an accurate diagnosis. The doctor may perform a...

Post

Enhanced Natural Killer Cell Therapy Shows Promise in Alzheimer’s

Megan Brooks November 02, 2023 An investigational natural killer cell (NK) therapy has shown promise in the treatment of Alzheimer’s disease (AD), in a small phase 1 proof-of-concept clinical trial. SNK01, being developed by NKGen Biotech, is an autologous, nongenetically modified NK cell product that has enhanced cytotoxicity and activating receptor expression. “When we give these enhanced...

Post

More Evidence Metformin May Be Neuroprotective

Megan Brooks October 31, 2023 TOPLINE: New research suggests terminating metformin may raise the risk for dementia in older adults with type 2 diabetes, providing more evidence of metformin’s potential neuroprotective effects. METHODOLOGY: TAKEAWAY: IN PRACTICE: The findings “corroborate the largely consistent evidence from other observational studies showing an association between metformin use and lower dementia incidence...

Post

Strength Training Promotes Knee Health, Lowers OA Risk

Heidi Splete November 02, 2023 TOPLINE: Strength training at any point in life is associated with a lower risk of knee pain and osteoarthritis, contrary to persistent assumptions of adverse effects. METHODOLOGY: TAKEAWAY: IN PRACTICE: “Our findings support the idea that the medical community should proactively encourage more people to participate in strength training to help reduce...

Post

Promising Topline Phase 2 Results for Novel Oral Alzheimer’s Drug

Megan Brooks October 25, 2023 T3D-959, an oral dual delta/gamma peroxisome proliferator-activated nuclear receptor (PPAR) agonist, has shown promise in a phase 2 randomized, placebo-controlled study of adults with mild-to-moderate Alzheimer’s disease (AD). Topline results provide “clinical evidence of a modification of multiple AD pathologies associated with amyloid plaque burden,” said John Didsbury, PhD, chief executive officer...